iifl-logo

Hannah Joseph Hospital Ltd Company Summary

Add as a Preferred Source on Google
60.18
(-2.11%)
Feb 27, 2026|12:00:00 AM

Hannah Joseph Hospital Ltd Summary

Hannah Joseph Hospital Limited is one of the first centres in Asia to adopt DTI Fibertracking 3.0, a revolutionary navigation tool for brain tumour surgeries. To provide comprehensive range of neurosurgery and neurology services, Mosesjoseph Arunkumar established a hospital in the name of Hannah Joseph Hospital as a sole proprietorship in Madurai town of Tamil Nadu, in 2008. On September 9, 2008, the hospital became a member of Nursing Homes and Hospital Board, Indian Medical Association Tamil Nadu State.Later, Hannah Joseph Hospital Limited was incorporated as a private limited as Hannah Joseph Hospital Private Limited at Tamil Nadu as a private limited company , dated October 24, 2011, issued by the Registrar of Companies, Tamil Nadu.

Subsequently, Company changed its status to a public limited company and the name of the Company was changed to Hannah Joseph Hospital Limited vide fresh certificate of incorporation dated July 29, 2022. Company is being promoted by Mosesjoseph Arunkumar (Neurosurgeon at Hospital), and Fenn Kavitha Fenn Arunkumar (Consultant Psychiatrist at Hospital).Recognizing the demand for increased bed capacity and lack of space, the hospital was relocated in year 2020. This expansion mark a notable development for the Company, signifying sustained growth and progress in the healthcare services.

Hannah Jospeh Hospital Limited, a multi-speciality healthcare provider, strategically located in Madurai, operating in a two acres campus, centrally air-conditioned hospital with central water heating system with a combined bed capacity of 150 beds.Company is rendering medical services to public through Hannah Joseph Hospital, which is a renowned center of excellence for Neurology, Neurosurgery and Psychiatry treatment. The medical facility encompasses full-fledged department of neuroradiology and has added the department of cardiac sciences with a Cath lab and cardiac operation theatres. The Company now performs complex coronary angioplasties and open-heart Surgeries.

Currently, their primary focus is Neurology, Cardiology, Physchiarty and Trauma healthcare where the Hospital has a understanding of global nuances, customer culture and the mindset of medical professionals and where there is a significant need for quality and affordable healthcare services.In 2023, rare case of the Temporomandibular Joint Replacement Surgery was done by the Department of Oral Maxillofacial Surgery. In 2024, Brain lab Fiber tracking Navigation 3.0 version for removing brain tumours has been launched. Company raised Rs 42 Crore by issuing 60,00,000 equity shares of Rs 10 each through IPO on January 28, 2026.The Company is proposing to set up he Proposed Radiation Oncology Centre adjacent to the current hospital campus in 2026.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.